Back to Trials
NCT07496255NARecruiting

Virtual Reality Cognitive Intervention for Critically Ill Delirium Survivors (VR-Cog)

Indiana University

Start Date

3/19/2026

Completion Date

7/15/2027

Summary

The purpose of this study is to measure the feasibility, acceptability of virtual reality (VR) brain games and estimate their effect on memory, attention, and mood for ICU survivors. The VR program will be used at home through a headset and hand controls.

Detailed Description

Acute respiratory failure (ARF) accounts for 2 million admissions to adult intensive care units (ICUs) in the United States annually, and up to 80% of older adults with ARF suffer delirium, a form of ICU-related acute brain dysfunction. Delirium doubles the risk for new cognitive impairment or dementia within 12 months of ICU discharge. In addition, delirium survivors frequently develop related mental health and quality of life impairments. Unfortunately, there are few effective or scalable interventions to improve cognitive outcomes for ICU survivors. Primary Objective Aim 1: Measure the feasibility, acceptability, and adherence of VR-Cog in older adult ICU delirium survivors at risk for ICU-acquired MCI and ADRD. Secondary Objective Aim 2: Estimate the effect of VR-Cog on cognitive performance among older adult ICU delirium survivors. Tertiary/Exploratory/Correlative Objectives Aim 3: Explore the effects of VR-Cog on mental health (depression and anxiety).

Eligibility Criteria

Age Range: 50 years to No maximum

Inclusion Criteria: * Adults aged 50 years or older * English speaking * Admitted to the intensive care unit (ICU) with acute respiratory failure/invasive mechanical ventilation * Screening positive for delirium (using Richmond Agitation Sedation Scale and Confusion Assessment Method for the ICU) Exclusion Criteria: * Acute neurologic injury such as stroke, traumatic brain injury, brain mass, intracranial hemorrhage, seizures, or central nervous system infection * Chronic cognitive or physical function deficit preventing participation in study interventions or assessments (determined by chart diagnoses and direct participant interview) * Chronic cognitive impairment (including mild cognitive impairment or dementia) identified by chart diagnosis, prescription of anti-dementia medications, or Informant Questionnaire on Cognitive Decline in the Elderly Score (IQCODE) \>3.3 obtained from family caregiver * Severe, uncorrected vision or hearing impairment preventing participation in intervention or outcomes assessments * Admitted with acute alcohol or drug intoxication or withdrawal * Severe, uncontrolled psychiatric disorder (bipolar disorder or schizophrenia) * History of severe vertigo, motion-induced sickness, headaches, light sensitivity, seizures, or prior intolerance of virtual reality (VR) * Receiving comfort care measures or not expected to survive the hospitalization * Prisoners or patients unable to provide consent * Not expected to be discharged home from the hospital, or living more than 50 miles from the nearest recruitment site, or homeless

Interventions

DEVICE

VR-based cognitive training program

DEVICE

VR-based attention control

Interested in This Trial?

Contact the trial locations directly using the information below to learn more about enrollment.

Expressing interest lets you review the study and consent before we connect you with the research site.

Conditions

Intensive Care Unit DeliriumIntensive Care Acquired Cognitive ImpairmentPost Intensive Care Unit SyndromeVirtual Reality Cognitive Training

Locations

IU Health Methodist Hospital

Indianapolis, Indiana 46202

United States